Publications

Journals

Marston S; Copeland O; Jacques A; Livesey K; Tsang V; McKenna WJ; Jalilzadeh S; Carballo S; et alRedwood C; Watkins H. (31 Jul 2009). Evidence From Human Myectomy Samples That MYBPC3 Mutations Cause Hypertrophic Cardiomyopathy Through Haploinsufficiency. CIRC RES. 105:219-U39. DOI.
Jacques AM; Copeland O; Messer AE; Gallon CE; King K; McKenna WJ; Tsang VT; Marston SB. (Aug 2008). Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle. J MOL CELL CARDIOL. 45:209-216. DOI.
Mirza M; Robinson P; Kremneva E; Copeland O; Nikolaeva O; Watkins H; Levitsky D; Redwood C; et alEl-Mezgueldi M; Marston S. (4 May 2007). The effect of mutations in alpha-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filaments. J Biol Chem. 282:13487-13497. DOI.

Garcia EA; Kanda GK; Lyon A; Gallon CE; Messer AE; O'Gara P; Marston SB; Harding SE. Tonic support of contraction involving the PI3 kinase pathway in ventricular myocytes from failing human heart. 44:752-753. (Apr 2008). DOI.
Marston S; Copeland O; Jacques A. MYBP-C mutation, expression and phosphorylation in non-failing, failing and HOCM human heart muscle. 42:S73-S73. (Jun 2007). DOI.
Jacques A; Copeland O; McKenna W; Tsang V; Marston S. MyBP-C phosphorylation in donor, failing and HOCM human heart muscle. 44:730-731. (Apr 2008). DOI.
Carballo S; Copeland O; Livesey K; Jacques A; McKenna W; Redwood C; Marston S; Watkins H. Direct evidence in man for haploinsufficiency as the mechanism of action of myosin-binding protein C mutations that cause hypertrophic cardiomyopathy. 94:A105-A105. (Jul 2008).